{
  "trial_type": "IPCase",
  "date": {
    "era": "Heisei",
    "year": 22,
    "month": 2,
    "day": 24
  },
  "case_number": "平成21(行ケ)10399",
  "case_name": "審決取消請求当事者参加事件",
  "court_name": "知的財産高等裁判所",
  "right_type": "特許権",
  "lawsuit_type": "行政訴訟",
  "lawsuit_id": "38496",
  "detail_page_link": "https://www.courts.go.jp/app/hanrei_jp/detail7?id=38496",
  "full_pdf_link": "https://www.courts.go.jp/app/files/hanrei_jp/496/038496_hanrei.pdf",
  "contents": "James M.Foran\nPharmacokinetic Study of Single Doses of Oral Fludarabine\nPhosphate in Patients With \"Low-Grade\" Non-Hodgkin's Lymphoma\nand B-Cell Chronic Lymphocytic Leukemia Journal of Clinical\nOncology\n50 100mg\n0.1 5mg\n40 100mg avicel\n10mg Na\n0.5 10mg\n99.19 fludara 1 70mg\n0.02 9H\n0.12 O D\n9H\n0.02 9H\n0.02 9H\n0.05 O D\n9H\n0.1 O D\n9H\n0.1 O D\n9H\n0.02 O D\n9H\n0.06 O D\n9H\n0.02 9H\nO D 9H\nO, O 9H\nD\n0.1 D\n9H\n0.1 D\n9H\n10mg\nfludara 10mg\n50 100mg\n0.1 5mg 40 100mg\navicel 10mg Na\n0.5 10mg\n100mg 0.1 5mg 40\n100mg avicel 1 10mg Na\n0.5 10mg\nNa\nWO99/29710\nWO99/29710\npH\npH\n99.19%\navicel\n50 100mg\n0.1 5mg 40 100mg\navicel 1 10mg Na\n0.5 10mg\navicel\nNa\nAccelerated Storage Test\n99.19\navicel\n99.19\navicel\n99.5\n99.19\n99.19\nNa\navicel\n3-i\nWO99/297\nWO99/29710\nWO99/29710 WO99/29710 99.19\nWO99/29710\nWO99/29710\npH\n99.19%\n1 2 3\n60 90mg\n0.5 1mg\n50 90mg avicel\n2.5 5mg Na\n1 3mg\n99.19 1 50mg\n74.75mg\n0.75mg\n60.00mg avicel\n3.00mg Na\n1.5 2.00mg\n99.19 10mg\n99.37\n99.57\n99.80\n99.85\nmg\n0.1 1mg\n0.1 5mg\n0.01 0.1mg\n0.01 0.1mg\nmg\n0.1 0.8mg\n0.1 mg\n0.01 0.05mg\n0.01 0.05mg\n2.250mg\n0.450mg\n1.187mg\n0.036mg\n0.036mg\n99.19\n3,903,297\nNa\nWO00/71134\nNa\nWO99/40846\nWO00/50423\nNa\n6,197,785 EP1065206 EP819430\nEP1065204 EP985666\nNa\n99.5\nWO99/29710 99.19\n99.19\n100mg 75mg\n10 50mg 10 20mg\navicel\n100 250mg\n120 200mg 130 180mg\n0.02\n9H\n0.12 O D\n9H\n0.02 9H\n0.02 9H\n0.05 O D\n9H\n0.1 O D\n9H\n0.1 O D\n9H\n0.02 O D\n9H\n0.06 O D\n9H\n0.02 9H\nO D 9H\nO, O\n9H D\n0.1 D\n9H\n0.1 D\n9H\nmg mg 2.250mg\n0.1 1mg 0.1 0.8mg 0.450mg\n0.1 5mg 0.1 mg 1.187mg\n0.01 0.1mg 0.01 0.05mg 0.036mg\n0.01 0.1mg 0.01 0.05mg 0.036mg\n99.19\navicel\n99.19 10.00mg\n74.75mg\n0.75mg\navicel 60.00mg\nNa 3.00mg\n1.5 2.00mg\nAlu\n98 97.67\n99.19 99.57\n99.19\n97.67\n99.19\n99.37 99.57\nWO99/29710\n99.8\n99.85\n2001 12 20\n101 64-510.4 2002 20\n60/404 399\n/\n2 1 99.19\n99.19\n0.02\n9H\n0.73\n99.19 1 70mg\navicel Na\nAlu\n97.67\n99.19\n99.37 99.57\nWO99/29710\n99.8\n99.85\n99.37 99.57\n99.37 99.57\n99.17\nJournal of Clinical Oncology\n10mg\nfludara 10mg\n50 100mg\n0.1 5mg 40 100mg\navicel 10mg Na\n0.5 10mg\n.\n.\n2910U.S.P 3cps\nlactose\nNa\n99.19\nfludara\n99.19\n99.19\n99.5\n99.19\nAlu\nDE\n4141454 A1\npH\npH\npH\npH\npH\n6,197,785\nNa\navicel\navicel\nNa\nHPLC HPLC\n8.11%\n91.89\nAccelerated\nStorage Test\n1.18 98.82 100 1.18\n99.19\n0.73\n"
}